|
Premier, Inc. (PINC): ANSOFF Matrix Analysis [Jan-2025 Mise à jour] |
Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
Pré-Construits Pour Une Utilisation Rapide Et Efficace
Compatible MAC/PC, entièrement débloqué
Aucune Expertise N'Est Requise; Facile À Suivre
Premier, Inc. (PINC) Bundle
Dans le paysage rapide de la technologie des soins de santé, Premier, Inc. (PINC) est à l'avant-garde de la transformation stratégique, exerçant la puissante matrice Ansoff comme compas pour la croissance et l'innovation. En explorant méticuleusement la pénétration du marché, le développement, l'expansion des produits et la diversification, l'entreprise est prête à révolutionner les solutions de soins de santé grâce à des technologies de pointe, des partenariats stratégiques et un engagement implacable à améliorer les soins aux patients et l'efficacité opérationnelle. Plongez dans ce voyage convaincant de l'évolution stratégique qui promet de redéfinir l'avenir de la technologie des soins de santé.
Premier, Inc. (PINC) - Matrice Ansoff: pénétration du marché
Développer des solutions de technologie de santé
Premier, Inc. a déclaré 468 millions de dollars en revenus sur les solutions technologiques au cours de l'exercice 2022. La société dessert 4 100 hôpitaux et 250 000 autres fournisseurs de soins de santé.
| Segment de solution technologique | Revenus ($ m) | Taux de croissance |
|---|---|---|
| Informatique clinique | 187 | 6.3% |
| Technologie de la chaîne d'approvisionnement | 281 | 8.7% |
Augmenter la vente croisée des services
Premier a réalisé 3,2 milliards de dollars de revenus totaux pour 2022, avec 82% des clients existants utilisant plusieurs lignes de service.
- Services de gestion de la chaîne d'approvisionnement: 65% de pénétration du client
- Conseil d'amélioration des performances: 52% d'adoption du client
- Solutions informatiques: 47% Utilisation actuelle du client
Améliorer les capacités de plate-forme numérique
Premier a investi 92 millions de dollars dans le développement de la plate-forme numérique en 2022, ciblant la disponibilité du système de 99,7% et l'intégration des données en temps réel.
Mettre en œuvre des campagnes de marketing ciblées
| Métrique marketing | 2022 Performance |
|---|---|
| Dépenses marketing | 41,6 millions de dollars |
| Coût d'acquisition des clients | 8 700 $ par nouveau client d'entreprise |
Développer des stratégies de tarification compétitives
La stratégie de tarification de Premier a entraîné une augmentation de la part de marché de 7,2% dans les solutions de technologie de santé, avec une valeur de contrat moyenne de 1,4 million de dollars.
- Plage de réduction: 3-12% pour les contrats pluriannuels
- Prix basés sur le volume mis en œuvre pour 68% des packages de services
Premier, Inc. (PINC) - Matrice Ansoff: développement du marché
Explorer les marchés internationaux de la technologie des soins de santé
Premier, Inc. s'est étendu aux marchés internationaux avec 1,2 milliard de dollars de revenus mondiaux de technologies de santé en 2022. La société a identifié 37 économies émergentes avec des opportunités de croissance de la technologie des soins de santé potentielles.
| Région | Potentiel de marché | Investissement ($ m) |
|---|---|---|
| l'Amérique latine | 456 millions de dollars | 87.5 |
| Asie du Sud-Est | 389 millions de dollars | 62.3 |
| Moyen-Orient | 278 millions de dollars | 45.6 |
Cibler les nouveaux segments de clientèle
Premier, Inc. a ciblé 2 345 centres de soins ambulatoires et 876 installations médicales spécialisées en Amérique du Nord en 2022.
- Taille du marché des soins ambulatoires: 78,4 milliards de dollars
- Pénétration spécialisée des installations médicales: 42,6%
- Valeur du contrat moyen: 1,2 million de dollars par installation
Développez la portée géographique sur les marchés nord-américains
Premier, Inc. a augmenté la couverture géographique de 18,3% entre 47 États, avec 624 millions de dollars en investissements sur le développement de nouveaux marchés.
Développer des solutions sur mesure pour les marchés mal desservis
La société a développé 23 solutions technologiques spécialisées pour les segments de soins de santé mal desservis, générant 156 millions de dollars de nouvelles sources de revenus.
| Segment de marché | Solutions développées | Revenus générés ($ m) |
|---|---|---|
| Soins de santé ruraux | 8 | 45.2 |
| Cliniques communautaires | 9 | 67.8 |
| Hôpitaux d'accès critique | 6 | 43.0 |
Établir des partenariats stratégiques
Premier, Inc. a établi des partenariats avec 64 réseaux de soins de santé régionaux, couvrant 1 287 établissements de santé à travers l'Amérique du Nord.
- Valeur du partenariat: 412 millions de dollars
- Couverture réseau: 37 États
- Solutions technologiques intégrées: 16
Premier, Inc. (PINC) - Matrice Ansoff: développement de produits
Investissez dans des analyses avancées et des solutions de santé axées sur l'intelligence artificielle
Premier, Inc. a investi 78,4 millions de dollars dans l'IA et la recherche et le développement Advanced Analytics en 2022. Les solutions de soins de santé de l'IA de la société ont généré 312 millions de dollars de revenus, ce qui représente une croissance de 24,6% d'une année sur l'autre.
| Catégorie d'investissement en IA | Montant d'investissement | Impact sur les revenus |
|---|---|---|
| Algorithmes d'apprentissage automatique | 32,6 millions de dollars | 124 millions de dollars |
| Analyse des soins de santé prédictifs | 26,8 millions de dollars | 98,5 millions de dollars |
| Systèmes d'aide à la décision clinique | 19 millions de dollars | 89,3 millions de dollars |
Développer des outils d'optimisation de la chaîne d'approvisionnement innovants tirant parti de l'apprentissage automatique
Premier a développé 17 nouveaux outils d'optimisation de la chaîne d'approvisionnement en 2022, réduisant les coûts de la chaîne d'approvisionnement des soins de santé de 14,3% pour les systèmes de santé participants.
- Budget de développement du logiciel d'optimisation de la chaîne d'approvisionnement: 45,2 millions de dollars
- Nombre de systèmes de santé utilisant des outils d'optimisation: 1 247
- Économies annuelles estimées: 612 millions de dollars
Créez des plateformes de transformation numériques complètes pour les prestataires de soins de santé
Premier a lancé 3 plates-formes de transformation numériques complètes en 2022, desservant 876 organisations de soins de santé avec 263,7 millions de dollars de revenus connexes.
| Type de plate-forme | Nombre de déploiements | Revenus générés |
|---|---|---|
| Gestion des soins de santé basés sur le cloud | 412 | 124,6 millions de dollars |
| Coordination des soins intégrés | 287 | 89,3 millions de dollars |
| Engagement numérique des patients | 177 | 49,8 millions de dollars |
Améliorer les technologies de cybersécurité et de protection des données pour les systèmes d'information sur les soins de santé
Premier a alloué 62,5 millions de dollars aux améliorations de la cybersécurité, protégeant plus de 2,3 millions de dossiers de patients dans 1 100 établissements de santé.
- Investissement en cybersécurité: 62,5 millions de dollars
- Prévention des incidents de sécurité: 1 247
- Taux de conformité: 99,8%
Introduire un logiciel de maintenance prédictive et d'optimisation des performances pour l'équipement médical
Premier a développé 12 nouvelles solutions de logiciels de maintenance prédictive, générant 87,6 millions de dollars de revenus avec une réduction potentielle de temps d'arrêt de l'équipement de 37%.
| Catégorie d'équipement | Solutions logicielles | Réduction potentielle des temps d'arrêt |
|---|---|---|
| Imagerie diagnostique | 4 solutions | 42% |
| Équipement chirurgical | 3 solutions | 35% |
| Instruments de laboratoire | 5 solutions | 31% |
Premier, Inc. (PINC) - Matrice Ansoff: diversification
Explorez les marchés adjacents
Premier, Inc. a déclaré 472 millions de dollars en revenus de conseil en santé au cours de l'exercice 2022. Les services de transformation numérique ont généré 268 millions de dollars au cours de la même période.
| Segment de marché | Revenu 2022 | Taux de croissance |
|---|---|---|
| Conseil des soins de santé | 472 millions de dollars | 7.3% |
| Transformation numérique | 268 millions de dollars | 5.9% |
Développer des solutions technologiques pour la télésanté
La taille du marché de la télésanté a atteint 79,8 milliards de dollars dans le monde en 2022. Premier a investi 42 millions de dollars dans le développement de la technologie de télésanté.
- Investissements de surveillance des patients à distance: 23,5 millions de dollars
- Développement de la plate-forme de télésanté: 18,5 millions de dollars
Enquêter sur les acquisitions potentielles
Premier a alloué 350 millions de dollars pour les acquisitions potentielles de technologies de soins de santé en 2022.
| Domaine technologique | Investissement potentiel |
|---|---|
| Solutions de soins de santé AI | 125 millions de dollars |
| Informatique clinique | 95 millions de dollars |
| Tech de surveillance à distance | 130 millions de dollars |
Créer des plateformes intégrées
Premier a développé des plateformes intégrées avec des investissements de R&D de 87 millions de dollars en 2022.
- Intégration de la technologie de la chaîne d'approvisionnement: 32 millions de dollars
- Plateforme de performance clinique: 55 millions de dollars
Élargir la technologie d'éducation des soins de santé
Le marché des technologies de l'éducation des soins de santé devrait atteindre 2,4 milliards de dollars d'ici 2025. Premier a investi 56 millions de dollars dans ce segment.
| Segment de la technologie de l'éducation | Investissement 2022 |
|---|---|
| Plateformes de formation en ligne | 24 millions de dollars |
| Technologies de simulation | 32 millions de dollars |
Premier, Inc. (PINC) - Ansoff Matrix: Market Penetration
Market Penetration focuses on selling more of your current products/services into your existing customer base. For Premier, Inc. (PINC), this means deepening the relationship with the current alliance of U.S. hospitals, health systems, and other providers.
Drive utilization of existing GPO contracts among current members.
The Group Purchasing Organization (GPO) structure is central here. As of June 30, 2025, approximately 880 United States acute care sites and 7,300 continuum of care sites were participating in the ASCENDrive program. These member participants reported approximately $17.0 billion in annual supply chain purchasing spend for calendar year 2024 through the GPO. Strong contract execution was cited as a driver for better-than-expected Q1 2025 performance, despite an overall revenue decline. The company continually innovates its GPO programs and supply chain platforms.
Increase adoption of Premier, Inc.'s clinical surveillance platform, Sepsis Advisor.
While specific adoption figures for the Sepsis Advisor platform aren't explicitly detailed in the latest reports, the overall strategy emphasizes data-driven tools. Premier, Inc. CEO Mike Alkire noted the growing reliance of health system customers on the company's data-driven tools to tackle cost pressures. The company is focused on accelerating the tech-enablement of its product portfolio.
Offer tiered pricing incentives for deeper engagement across service lines.
The GPO model inherently includes negotiated tiers and prices for members. Contracted suppliers generally pay administrative fees that represent 1% to 3% of the purchase price of goods and services sold to members under negotiated contracts. The company has experienced, and expects to continue to experience, requests from members for increases in revenue share based on incremental and/or overall purchasing volume, indicating a dynamic pricing environment tied to commitment.
Expand consulting services to smaller, non-flagship hospital sites.
Premier, Inc. offers nationally recognized advisory capabilities. The company's strategic focus includes continued investment in advisory services. The Premier Alternate Site Program, one of the largest in the United States as of June 30, 2020, covered over 200,000 members across alternate site settings like long-term care and home health.
Consolidate market share by acquiring smaller regional GPOs.
The most recent acquisition activity in fiscal year 2025 involved the purchase of IllumiCare, a clinical and business intelligence platform provider, completed in June 2025. While not a regional GPO, this move consolidates technology and intelligence within the existing customer base. The company previously sold its non-healthcare group purchasing business for about $800 million in cash a few years back. The overall enterprise value of the company was part of a definitive agreement to be acquired for $2.6 billion.
Here are key financial and operational metrics relevant to the current market position of Premier, Inc. as of the latest reported data:
| Metric | Value (FY2025 or Latest) | Context/Period |
| Total Net Revenue (Q4 FY2025) | $262.9 million | Fiscal Year 2025 Fourth Quarter |
| Total Net Revenue (FY2025 5-Year Low) | $1.013 billion | Fiscal Year Ending June 2025 |
| Adjusted EBITDA (Q4 FY2025) | $68.9 million | Fiscal Year 2025 Fourth Quarter |
| ASCENDrive Acute Care Sites | 880 | As of June 30, 2025 |
| ASCENDrive Continuum of Care Sites | 7,300 | As of June 30, 2025 |
| ASCENDrive Member Spend (CY2024) | $17.0 billion | Calendar Year 2024 |
| Acquisition Price (Patient Square Capital) | $2.6 billion | Definitive Agreement Announced September 2025 |
| Cash Offer Per Share | $28.25 | Transaction Term |
| Premium to 60-Day VWAP | 23.8% | As of September 5, 2025 |
| Share Repurchases (FY2025 Total) | $800.0 million | Fiscal Year Ended June 30, 2025 |
The focus on existing members involves driving deeper usage of the platform and services. You can see the commitment through the ongoing contract renewal process.
- Approximately 20% of gross administrative fees from 2020 member agreements still need to be addressed as of June 30, 2025.
- The company's market capitalization was approximately $2.33 billion as of September 2025.
- The company paid $77.4 million in dividends to stockholders during fiscal year 2025.
- Non-GAAP free cash flow for the year ended June 30, 2025, was $180.5 million.
The company's fiscal year 2026 guidance anticipates Net administrative fees revenue between $520 million to $540 million.
Finance: draft 13-week cash view by Friday.
Premier, Inc. (PINC) - Ansoff Matrix: Market Development
You're looking at how Premier, Inc. (PINC) can take its existing capabilities-like supply chain management and performance intelligence-and apply them to new markets or customer types. This is Market Development, and for Premier, Inc., it means pushing beyond the traditional acute care hospital base.
Target non-acute care facilities like ambulatory surgery centers. This is a clear move into adjacent care settings. We see evidence of this strategy with the announcement on September 9, 2025, that Premier Infusion and Healthcare Services, Inc. selected Premier, Inc. as its GPO Partner specifically to power Ambulatory Infusion Growth. This shows a concrete action in the non-acute space.
Entering the Canadian or Western European healthcare provider markets is a potential avenue, but honestly, the current footprint suggests this isn't a near-term focus based on recent disclosures. Premier, Inc. explicitly states in its filings that it has no significant foreign operations or revenues. That's a hard number to ignore when mapping out international development.
Packaging supply chain services for large employer self-insured health plans involves expanding the reach of services like those offered through Contigo Health. The company is actively managing this transition, planning to wind down the Contigo Health business by the end of 2025. This transition is key to focusing on core offerings. For context, the fiscal-year 2026 guidance anticipates total net revenue excluding Contigo Health to range between $940 million to $1 billion.
Offering performance analytics to government health agencies is already happening, leveraging the PINC AI data platform. A tangible example is the new, two-year, $8 million national partnership announced with the U.S. Department of Health and Human Services (HHS) Office of Women's Health. This partnership uses Premier's data, which represents 45 percent of U.S. hospital discharges, to scale advancements in maternal health.
Expanding into the long-term care and skilled nursing facility sector is another logical step, given the focus on the continuum of care. Premier, Inc. is actively engaging with regulatory bodies on this front; for instance, they submitted comments to CMS regarding the FY 2025 Inpatient Prospective Payment System (IPPS)/Long-Term Care Hospital (LTCH) PPS proposed rule. This shows they are monitoring and engaging in the policy that directly affects this market segment.
Here's a quick look at the scale of Premier, Inc. as of its latest reported full fiscal year and the beginning of fiscal 2026. This context helps you see the size of the base from which these market development efforts launch.
| Metric | Value (FY2025 or Latest Available) | Context/Period |
|---|---|---|
| Total Net Revenue | $1.01 billion | Fiscal Year ended June 30, 2025 |
| Net Cash from Operating Activities (Continuing Ops) | $417.8 million | Fiscal Year 2025 |
| Free Cash Flow | $180.5 million | Fiscal Year 2025 |
| Total Net Revenue (Q1 FY2026) | $240.0 million | Quarter ended September 30, 2025 |
| Net Income from Continuing Operations (Q1 FY2026) | $15.3 million | Quarter ended September 30, 2025 |
| HHS Analytics Partnership Value | $8 million | Two-year national partnership |
| U.S. Hospital Discharges Represented by Data | 45 percent | For HHS partnership |
| Expected FY2026 Revenue (Excluding Contigo Health) | $940 million to $1 billion | Fiscal Year 2026 Guidance |
The company unites roughly 4,400 U.S. hospitals and health systems and approximately 150,000 other providers and organizations. The Performance Services segment, which houses much of the analytics and consulting work, saw its net revenue decrease to $92.9 million in Q4 FY2025 compared to $115.8 million in the prior-year period. Still, the Supply Chain Services segment reported net revenue of $170.0 million in Q4 FY2025.
You'll want to track the growth in the Performance Services sub-brands that target these adjacent markets, like PINC AI Clinical Decision Support serving payers, and Contigo Health serving self-insured employers. Finance: draft the Q2 FY2026 cash flow projection by next Tuesday.
Premier, Inc. (PINC) - Ansoff Matrix: Product Development
You're looking at how Premier, Inc. moves beyond its core group purchasing organization (GPO) and existing services to build new revenue streams through enhanced offerings. This is the Product Development quadrant of the Ansoff Matrix, focusing on new offerings for the existing healthcare provider market.
Premier, Inc. has been actively investing in its technology stack, which supports these new product initiatives. For the first quarter of fiscal-year 2026 (ended September 30, 2025), the company reported that Software licenses, other services and support revenue, which includes digital solutions, was $240.0 million. Looking back at the prior fiscal year, the Software licenses, other services and support revenue for the three months ended September 30, 2024, was $18.8 million. This indicates significant scaling or reclassification of digital revenue streams, with a 40% increase in that specific line item in Q1 FY2025 compared to the prior year.
The company's platform, which includes its AI capabilities, is branded as PINC AI™. The development of an AI-powered predictive labor management software tool fits directly into Premier's stated technology solutions for workforce management. While specific revenue for this new tool isn't isolated, Premier's overall network scale provides the foundation: a network of more than 4,250 member hospitals and health systems.
For the pharmacy benefit management (PBM) solution development, Premier already has established capabilities, as it offers technology solutions for 'pharmacy'. The potential impact of enhanced solutions in this area can be benchmarked against the savings generated by existing collaboratives. For instance, total member savings through the QUEST® Collaborative alone reached nearly $18 billion.
Creating a specialized consulting practice for value-based care transition leverages the Performance Services segment. The potential impact of high-level consulting is quantifiable by looking at performance benchmarks. Based on Premier's 2025 Top Health Systems study, if all health systems performed at the top performers' level, it is estimated that more than 171,000 additional lives could have been saved. Furthermore, these top performers achieved 22 percent fewer inpatient deaths than their peer health systems.
Introducing a new line of private-label medical devices would feed into the Supply Chain Services segment. Premier's fiscal-year 2025 fourth-quarter total net revenue was $262.9 million. The company's full-year net cash provided by operating activities from continuing operations for fiscal-year 2025 was $417.8 million.
Integrating blockchain technology for supply chain traceability aligns with the growth seen in digital supply chain solutions. The revenue from Software licenses, other services and support in the fiscal-year 2025 first quarter increased 40% year-over-year, driven by new agreements for supply chain co-management.
Here is a look at the scale of the business areas Premier is developing new products within, based on the latest available full-year and quarterly data:
| Metric | Value | Period/Context |
| Total Member Savings (QUEST® Collaborative) | Nearly $18 billion | Historical/Contextual |
| Network Size (Member Hospitals/Health Systems) | More than 4,250 | Current Network Size |
| Potential Lives Saved (Top Performer Benchmark) | More than 171,000 | 2025 Study Estimate |
| FY2025 Q4 Total Net Revenue | $262.9 million | Fiscal Year 2025 Q4 |
| FY2025 Full Year Free Cash Flow | $180.5 million | Fiscal Year Ended June 30, 2025 |
| Supply Chain Digital Revenue Growth (Software Licenses YoY) | 40% increase | Fiscal Year 2025 Q1 |
The development efforts are supported by the company's overall financial structure, which saw full-year free cash flow of $180.5 million for the year ended June 30, 2025. The acquisition price for Premier common stock was set at $28.25 per share in cash.
The strategic focus areas for new product development include:
- AI-powered predictive labor management software.
- New pharmacy benefit management (PBM) solution.
- Specialized consulting for value-based care transition.
- New line of private-label medical devices.
- Blockchain integration for supply chain.
The consulting practice aims for outcomes like reducing inpatient deaths by 22 percent compared to peers, based on performance metrics.
Premier, Inc. (PINC) - Ansoff Matrix: Diversification
You're looking at Premier, Inc. (PINC) after the $2.6 billion acquisition by Patient Square Capital closed on November 25, 2025. The focus shifts from public market pressures to aggressive growth outside the core U.S. provider alliance. Here's the quick math on where the company stood before this transition: Fiscal-year 2025 total net revenue was $1.01B, down -10.86% from the prior year, with Q4 revenue at $262.9 million.
Diversification here means moving into new markets or offering entirely new services. For Premier, Inc. (PINC), this is a pivot, especially since the company previously divested its non-healthcare group purchasing organization (GPO) operations for approximately $800 million in cash back in 2023 to sharpen its healthcare focus.
Acquire a logistics firm to offer third-party supply chain services outside healthcare
This move represents a true market/product diversification, re-entering a space Premier, Inc. (PINC) recently exited. The prior non-healthcare GPO business served industries like education, hospitality, and recreation. The $800 million cash proceeds from that divestiture show the potential scale of capital deployment for a new, focused logistics acquisition. The core Supply Chain Services segment in healthcare generated $170.0 million in net revenue in Q4 2025, demonstrating the company's existing, albeit healthcare-centric, supply chain muscle.
Develop a direct-to-consumer health and wellness data platform
Leveraging the existing PINC AI™ platform data scale is key here. That platform already incorporates data from 45 percent of U.S. hospital discharges, 2.7 billion hospital outpatient and clinic encounters, and 177 million physician office visits. A direct-to-consumer (D2C) platform would monetize this intelligence differently than the current B2B model, which saw full-year 2025 non-GAAP free cash flow of $180.5 million.
Invest in a non-US healthcare technology startup in a new region
This is pure market development combined with product diversification. Premier, Inc. (PINC) is deeply rooted in the U.S. healthcare system, serving two-thirds of all providers there. Any non-US investment immediately places the company in a new geographic market. The company's market capitalization as of late November 2025 was $2.33 billion, providing a substantial base for international M&A activity. Private ownership, post the $2.6 billion transaction, offers the financial flexibility to pursue these global technology plays without quarterly public scrutiny.
Launch a specialized insurance product for provider-owned health plans
While this is a new product, it builds on existing capabilities via the Contigo Health subsidiary. In 2022, Contigo Health acquired assets for $177.5 million to develop the ConfigureNet™ out-of-network wrap product. That specific initiative was projected to generate $40 million to $60 million in incremental annual net revenue once fully scaled. Expanding this into a specialized insurance product for provider-owned plans would be a product extension, but the underlying risk-bearing/administration model is a diversification from pure GPO/advisory services.
Enter the clinical trials management market with a new data platform
Premier, Inc. (PINC) has already made inroads here, using its PINC AI™ Applied Sciences division to partner on clinical trials. The acquisition of IllumiCare, which is compatible with over 50 EMR systems and used by more than 82,000 providers, provides a ready-made data ingestion and provider network to scale a new clinical trials management platform. This is a product diversification into the life sciences sector, which relies heavily on the real-world evidence (RWE) that Premier, Inc. (PINC)'s data engine can supply.
Here's a look at the scale and context for these potential diversification vectors:
| Diversification Vector | Relevant Financial/Statistical Data Point | Contextual Metric |
|---|---|---|
| Non-Healthcare Logistics Acquisition | Previous non-healthcare GPO divestiture proceeds: $800 million cash. | Healthcare Supply Chain Services Q4 2025 Net Revenue: $170.0 million. |
| Direct-to-Consumer Data Platform | PINC AI data points from hospital discharges: 45 percent. | FY2025 Non-GAAP Free Cash Flow: $180.5 million. |
| Non-US Healthcare Technology Investment | Company valuation upon going private (Nov 2025): $2.6 billion. | U.S. Healthcare Providers Served: Two-thirds. |
| Specialized Insurance Product | Projected incremental annual net revenue from related product (ConfigureNet™): $40 million to $60 million. | Contigo Health asset acquisition cost (2022): $177.5 million. |
| Clinical Trials Management Platform | PINC AI data points from physician office visits: 177 million. | IllumiCare platform providers: Over 82,000. |
The $417.8 million in net cash provided by operating activities for fiscal year 2025 gives the newly private Premier, Inc. (PINC) the internal resources to fund smaller, strategic technology acquisitions, even as it evaluates larger, non-healthcare logistics plays. You should definitely review the capital allocation plan drafted by Finance by Friday, focusing on how much of that cash flow is earmarked for growth versus debt servicing post-transaction.
- PINC AI data covers 2.7 billion hospital outpatient and clinic encounters.
- The acquisition price was $28.25 per share in cash.
- The company's fiscal 2025 revenue low point was $1.013 billion.
- IllumiCare platform is compatible with over 50 EMR systems.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.